Press Releases MedRx Co., Ltd

Equities

4586

JP3921220004

Delayed Japan Exchange Other stock markets 12:20:58 2024-05-08 am EDT			5-day change	1st Jan Change
118 ^JPY	+3.51%		+1.72%	-21.85%

Feb. 05	MedRx Co., Ltd announced that it has received ¥1.9076 million in funding from Evolution Capital Management LLC	CI
Jan. 11	MedRx Co., Ltd announced that it expects to receive ¥1.9076 million in funding from Evolution Capital Management LLC	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MedRx : Notice of revised forecasts of consolidated financial results	Apr. 23	PU
MEDRx : Collaboration Partner, Alto Neuroscience, Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia	Apr. 23	PU
MedRx : Fair Research Inc. Report ( October 12, 2023)	23-10-26	PU
MedRx : Prospect of NDA Re-Submission for MRX-5LBT	23-10-10	PU
MedRx : and Alto Neuroscience Enter Development Agreement for Novel CNS Targeted Medication	23-09-24	PU
MedRx : H1 FY2023 Business Highlight & Financial Results	23-08-28	PU
MedRx : Summary of Business Results for the Second Quarter Ended June 30, 2023 (Consolidated)	23-08-18	PU
MedRx : Fair Research Inc. Report ( April 10, 2023)	23-04-20	PU
MedRx : FY2022Business Highlight & Financial Results	23-03-02	PU
MedRx : Fair Research Inc. Report (September 14, 2022)	22-09-28	PU
MedRx : H1 FY2022 Business Highlight & Financial Results	22-08-29	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW